The present invention relates to enzyme inhibitors. More specifically, the present invention relates to ligand-directed covalent modification of proteins; method of designing same; pharmaceutical formulation of same; and method of use.
-
(2013/03/26)
More Articles about upstream products of 1313991-52-4
Get Best Price for1313991-52-4(3S,6S,10aS)-6-((S)-2-(methylamino)propanamido)-5-oxo-N-(3-((S)-2-oxotetrahydrofuran-3-ylcarbamoyl)benzyl)decahydropyrrolo[1,2-a]azocine-3-carboxamide